Together, these findings show that AT2 cell specific YY1 knockdown re-establishes antioxidant and iron homeostasis, limits GPX4-dependent ferroptosis, and markedly attenuates PS-NPs-induced pulmonary fibrosis, supporting YY1 as a potential therapeutic target in nanoplastic-related lung injury. Here, YY1 is linked to pulmonary fibrosis.